Physician Assistant, Medical · Sheridan, WY
NPI
1306577473
Since 2022
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
30 N Gould St Ste 52139
Sheridan, WY, 82801
Phone (307) 225-6993
Medicare paid, 2024
$63K
2,598 services
Medicare patients, 2024
236
Average age 72
Drug cost, 2024
$328K
5,743 prescriptions
Company payments, 2025
$167
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharae A Inman was code 99214 (office e&m - established), 574 times for 198 patients. In total Sharae A Inman billed 2,598 services in 25 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 574 | 198 | $72.33 | $42K |
| 99213 Office E&M - Established | Office | 183 | 119 | $47.25 | $8,647 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 152 | 21 | $0.09 | $13.61 |
| 20610 Joint Injection | Office | 27 | 23 | $40.35 | $1,090 |
| 99204 Office E&M - New | Office | 19 | 19 | $98.71 | $1,875 |
By year: 2022 $17K for 220 services; 2023 $63K for 1,320 services; 2024 $63K for 2,598 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharae A Inman prescribed most often to Medicare patients was Gabapentin, with 552 prescriptions and refills. In total Sharae A Inman wrote 5,743 Medicare prescriptions that cost $328K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 552 | 763 | 109 | $9,366 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 476 | 476 | 90 | $13K |
| Pregabalin Generic | 437 | 544 | 85 | $26K |
| Buprenorphine Hcl Generic | 422 | 474 | 85 | $18K |
| Tramadol Hcl Generic | 408 | 444 | 92 | $4,297 |
| Tizanidine Hcl Generic | 363 | 422 | 79 | $4,788 |
| Duloxetine Hcl Generic | 312 | 526 | 68 | $5,870 |
| Meloxicam Generic | 307 | 557 | 98 | $2,100 |
| Cyclobenzaprine Hcl Generic | 239 | 286 | 64 | $2,846 |
| Baclofen Generic | 228 | 288 | 58 | $3,992 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 190 | 190 | 33 | $5,732 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 182 | 190 | 38 | $35K |
| Fentanyl Generic | 113 | 113 | 14 | $13K |
| Diclofenac Sodium Generic | 87 | 106 | 23 | $1,816 |
| Lidocaine Generic | 84 | 91 | 23 | $9,688 |
Brand drugs: 258 claims; generic drugs: 5,485 claims; opioid claims: 1,543.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharae A Inman $167 ($167 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $167.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 5 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.